Enact Technologies files open offer for 26% stake in Hiliks at ₹72 per share
- Enact Technologies and associates filed a draft open offer to acquire 26% equity in Hiliks Technologies at ₹72 per share.
- The offer is triggered by a Share Purchase Agreement to buy 3.52% stake from existing promoter Extros Developers Private Limited.
- Post-offer, the acquirers' combined holding will increase to 51.59%, granting them management control.
- The tendering period runs from November 30, 2026, to December 11, 2026, with payments due by December 28, 2026.

*this image is generated using AI for illustrative purposes only.
Hiliks Technologies Limited shareholders are set to receive an open offer from Enact Technologies Private Limited and associated entities. The acquirers have filed a draft letter of offer with SEBI to acquire up to 36,92,000 equity shares, representing 26.00% of the expanded equity and voting share capital, at a price of ₹72 per share.
This mandatory open offer is triggered under Regulation 3(1) and Regulation 4 of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It follows the execution of a Share Purchase Agreement (SPA) dated October 5, 2026, wherein the acquirers agreed to purchase 5,00,000 equity shares constituting 3.52% of the expanded capital from Extros Developers Private Limited, the existing promoter.
Offer Structure and Pricing
The offer is unconditional regarding minimum acceptance levels. The price of ₹72 per share was determined as the highest among several parameters, including the negotiated price in the SPA and the volume-weighted average market price for sixty trading days preceding the public announcement. The total consideration for the open offer, assuming full acceptance, amounts to ₹26.58 crore.
The acquirers have deposited ₹6.64 crore in an escrow account with ICICI Bank Limited, representing 25% of the total offer consideration. Navigant Corporate Advisors Limited serves as the manager to the offer, while Skyline Financial Services Private Limited acts as the registrar.
Shareholding Pattern Changes
Upon completion of the SPA and the open offer, assuming full acceptance, the combined holding of the acquirers and persons acting in concert (PACs) will rise to 73,25,173 equity shares. This constitutes 51.59% of the expanded equity and voting share capital, granting them effective management control over the target company.
The existing promoters, Extros Developers Private Limited and Alpha Antibiotics Ltd, will cease to be promoters and will be reclassified as public shareholders in accordance with SEBI (LODR) Regulations. The new promoter group comprises Enact Technologies Private Limited, Penumatsa Venkata Raju, and Boyapati Venkata Lakshmi Narasimha Swamy, along with three PACs from the Kalidindi family.
| Metric | Pre-Offer (%) | Post-Offer (%) |
|---|---|---|
| Acquirers & PACs | 22.06 | 51.59 |
| Existing Promoters | 3.52 | 0.00 |
| Public Shareholders | 74.41 | 48.41 |
Timeline for Tendering
The public announcement was made on October 5, 2026, followed by the detailed public statement on October 12, 2026. The identified date for determining eligible shareholders is November 13, 2026. The tendering period for the open offer will commence on November 30, 2026, and close on December 11, 2026. Payment of consideration for accepted shares is scheduled for December 28, 2026.
What the Numbers Show
A divergence exists between the target company's operational scale and the acquirers' financial capacity. While Hiliks reported revenue from operations of ₹29.58 crore for FY26, the lead acquirer, Enact Technologies Private Limited, recorded zero revenue from operations for the same period, relying entirely on other income. However, the combined net worth of the three individual and corporate acquirers exceeds ₹53 crore, which is sufficient to cover the maximum offer consideration of ₹26.58 crore without external borrowing, as stated in the draft letter of offer.
Historical Stock Returns for Hiliks Technologies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.04% | +2.49% | +24.28% | +61.17% | +1.22% | 0.0% |
What strategic synergies or operational plans does Enact Technologies intend to implement to revitalize Hiliks Technologies, given Enact's current lack of operational revenue?
How might the transition of control to the Kalidindi family and associated PACs influence Hiliks' corporate governance structure and future capital allocation policies?
Will the existing public shareholders accept the ₹72 offer, or is there potential for a competing bid given the unconditional nature of the open offer?


































